Clinical data | |
---|---|
License data | |
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.932 |
Chemical and physical data | |
Formula | C19H29NO |
Molar mass | 287.447 gยทmol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Cycrimine (trade name Pagitane) is a central anticholinergic drug designed to reduce the levels of acetylcholine in the treatment of Parkinson's disease. Its mechanism of action is to bind to the muscarinic acetylcholine receptor M1.
Synthesis
See also
References
- Usdin E, Efron DH, eds. (1979). Psychotropic Drugs and Related Compounds (2nd ed.). Washington, DC: Pergamon Press. p. 218. ISBN 978-0-08-025510-1. OCLC 715151908.
- Denton JJ, Schedl HP, Lawson VA, Neier WB (1950). "Antispasmodics. VII. Additional Morpholinyl and Piperidyl Tertiary Alcohols". Journal of the American Chemical Society. 72 (8): 3795โ3796. doi:10.1021/ja01164a127.
External links
- Cycrimine at DrugLib.com